Apogee Therapeutics (APGE) Other Working Capital Changes (2024 - 2026)
Apogee Therapeutics (APGE) posted quarterly Other Working Capital Changes of -$802000.0 for Q1 2026, up 20.91% year-over-year from -$663318.1 in Q1 2025, and up 20.12% quarter-over-quarter from -$1.0 million in Q4 2025.
Apogee Therapeutics (APGE) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported Other Working Capital Changes for 3 consecutive years, with -$802000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 20.91% year-over-year to -$802000.0; the TTM figure through Mar 2026 stood at -$3.8 million (down 109.86% YoY), while the FY2025 annual figure was -$4.0 million, down 280.96% from the prior year.
- Other Working Capital Changes advanced to -$802000.0 in Q1 2026 per APGE's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at -$229000.0 in Q3 2024 and bottomed at -$1.0 million in Q1 2025.
- Historically, Other Working Capital Changes has averaged -$647555.6 across 3 years, with a median of -$802000.0 in 2026.
- Annual changes were most pronounced in 2025 — Other Working Capital Changes slumped 333.19% — and 2026, when it rose 20.91%.
- Apogee Therapeutics' Other Working Capital Changes stood at -$309000.0 in 2024, then slumped by 224.92% to -$1.0 million in 2025, then advanced by 20.12% to -$802000.0 in 2026.
- Business Quant data shows APGE's Other Working Capital Changes at -$802000.0 in Q1 2026, -$1.0 million in Q4 2025, and -$992000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Apogee Therapeutics | 10.14 Bn | 9.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.21 Mn |
| Jun 30, 2026 | -1.21 Mn |
| Jun 30, 2026 | -1.21 Mn |
| Mar 31, 2026 | -802,000.00 |
| Mar 31, 2026 | -802,000.00 |
| Mar 31, 2026 | -802,000.00 |
| Dec 31, 2025 | -1.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Sep 30, 2025 | -992,000.00 |
| Sep 30, 2025 | -992,000.00 |
| Sep 30, 2025 | -992,000.00 |
| Jun 30, 2025 | -971,000.00 |
| Jun 30, 2025 | -971,000.00 |
| Jun 30, 2025 | -971,000.00 |
| Mar 31, 2025 | -1.01 Mn |
| Mar 31, 2025 | -1.01 Mn |
| Mar 31, 2025 | -1.01 Mn |
| Dec 31, 2024 | -309,000.00 |
| Dec 31, 2024 | -309,000.00 |